109 related articles for article (PubMed ID: 23269015)
21. The impact of preoperative gonadotropin-releasing hormone agonist treatment on women with uterine fibroids: a meta-analysis.
Zhang Y; Sun L; Guo Y; Cheng J; Wang Y; Fan S; Duan H
Obstet Gynecol Surv; 2014 Feb; 69(2):100-8. PubMed ID: 25112488
[TBL] [Abstract][Full Text] [Related]
22. Differences in fibroid vascularity after three months of pre-treatment with leuprolide acetate or ulipristal acetate: A pilot study.
Frijlingh M; De Milliano I; Hehenkamp WJK; Huirne JAF
Eur J Obstet Gynecol Reprod Biol; 2020 Feb; 245():186-192. PubMed ID: 31679806
[TBL] [Abstract][Full Text] [Related]
23. Effect of nafarelin on uterine fibroids measured by ultrasound and magnetic resonance imaging.
Williams IA; Shaw RW
Eur J Obstet Gynecol Reprod Biol; 1990; 34(1-2):111-7. PubMed ID: 2137421
[TBL] [Abstract][Full Text] [Related]
24. Quantitative MRI of uterine leiomyomas during triptorelin treatment: reproducibility of volume assessment and predictability of treatment response.
Broekmans FJ; Heitbrink MA; Hompes PG; Schoute E; Falke T; Schoemaker J
Magn Reson Imaging; 1996; 14(10):1127-35. PubMed ID: 9065902
[TBL] [Abstract][Full Text] [Related]
25. Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications.
Yamashita Y; Torashima M; Takahashi M; Tanaka N; Katabuchi H; Miyazaki K; Ito M; Okamura H
Radiology; 1993 Dec; 189(3):721-5. PubMed ID: 8234695
[TBL] [Abstract][Full Text] [Related]
26. Diffusion-weighted imaging properties of uterine fibroids pre- and post-uterine fibroid embolisation.
Kirpalani A; Chong J; Yang N; Jenkins SJ; Nisenbaum R; Prabhudesai V; Anthwal S; Colak E
Eur J Radiol; 2014 Sep; 83(9):1620-5. PubMed ID: 24976500
[TBL] [Abstract][Full Text] [Related]
27. Value of magnetic resonance imaging in predicting efficacy of GnRH analogue treatment for uterine leiomyoma.
Takahashi K; Okada M; Imaoka I; Sugimura K; Miyazaki K
Hum Reprod; 2001 Sep; 16(9):1989-94. PubMed ID: 11527910
[TBL] [Abstract][Full Text] [Related]
28. Rapid reduction of leiomyoma volume during treatment with the GnRH antagonist ganirelix.
Flierman PA; Oberyé JJ; van der Hulst VP; de Blok S
BJOG; 2005 May; 112(5):638-42. PubMed ID: 15842290
[TBL] [Abstract][Full Text] [Related]
29. Gonadotrophin hormone-releasing hormone analogue treatment of fibroids.
Shaw RW
Baillieres Clin Obstet Gynaecol; 1998 Jun; 12(2):245-68. PubMed ID: 10023421
[TBL] [Abstract][Full Text] [Related]
30. [Effect of GnRH analogues pre-treatment on myomectomy outcomes in reproductive age women].
Hudecek R; Ivanová Z; Smerdová M; Pánková S; Krajcovicová R
Ceska Gynekol; 2012 Apr; 77(2):109-17. PubMed ID: 22702067
[TBL] [Abstract][Full Text] [Related]
31. [The percutaneous treatment of uterine fibromas by means of transcatheter arterial embolization].
Golfieri R; Muzzi C; De Iaco P; Maffei M; Giampalma E; Amore B; Muzzupapa G; Baroncini S; Bovicelli L
Radiol Med; 2000; 100(1-2):48-55. PubMed ID: 11109452
[TBL] [Abstract][Full Text] [Related]
32. Symptomatic fibroleiomyomata: MR imaging of the uterus before and after uterine arterial embolization.
Jha RC; Ascher SM; Imaoka I; Spies JB
Radiology; 2000 Oct; 217(1):228-35. PubMed ID: 11012449
[TBL] [Abstract][Full Text] [Related]
33. Doppler assessment of uterine blood flow changes in patients with fibroids receiving the gonadotropin-releasing hormone agonist Buserelin.
Matta WH; Stabile I; Shaw RW; Campbell S
Fertil Steril; 1988 Jun; 49(6):1083-5. PubMed ID: 2967195
[TBL] [Abstract][Full Text] [Related]
34. Prediction of early response to uterine artery embolization in fibroids: value of MR signal intensity ratio.
Noda Y; Kanematsu M; Goshima S; Kondo H; Watanabe H; Kawada H; Kawai N; Tanahashi Y; Bae KT
Magn Reson Imaging; 2015 Jan; 33(1):51-5. PubMed ID: 25271135
[TBL] [Abstract][Full Text] [Related]
35. Hypointensity on postcontrast MR imaging from compression of the sacral promontory in enlarged uterus with huge leiomyoma and adenomyosis.
Uotani K; Monzawa S; Adachi S; Takemori M; Kaji Y; Sugimura K
Magn Reson Med Sci; 2007; 6(2):61-6. PubMed ID: 17690535
[TBL] [Abstract][Full Text] [Related]
36. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status.
Parsanezhad ME; Azmoon M; Alborzi S; Rajaeefard A; Zarei A; Kazerooni T; Frank V; Schmidt EH
Fertil Steril; 2010 Jan; 93(1):192-8. PubMed ID: 19135657
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic response assessment of high intensity focused ultrasound therapy for uterine fibroid: utility of contrast-enhanced ultrasonography.
Zhou XD; Ren XL; Zhang J; He GB; Zheng MJ; Tian X; Li L; Zhu T; Zhang M; Wang L; Luo W
Eur J Radiol; 2007 May; 62(2):289-94. PubMed ID: 17258417
[TBL] [Abstract][Full Text] [Related]
38. Scaled Signal Intensity of Uterine Fibroids on T2-Weighted MR Imaging as a Predictor of the Potential Response to Uterine Fibroid Embolization.
Kang SH; Lee SJ; Jeon GS; Yoon SW
J Vasc Interv Radiol; 2017 Jun; 28(6):844-849. PubMed ID: 28291713
[TBL] [Abstract][Full Text] [Related]
39. Volumetric MR-guided high-intensity focused ultrasound ablation with a one-layer strategy to treat large uterine fibroids: initial clinical outcomes.
Kim YS; Kim JH; Rhim H; Lim HK; Keserci B; Bae DS; Kim BG; Lee JW; Kim TJ; Choi CH
Radiology; 2012 May; 263(2):600-9. PubMed ID: 22403170
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of tibolone as "add-back therapy" in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids.
Morris EP; Rymer J; Robinson J; Fogelman I
Fertil Steril; 2008 Feb; 89(2):421-8. PubMed ID: 17572410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
